Table 4.
Examples of representative 4-oxo-1,4-dihydropyridine derivatives developed by Boehringer Ingelheim GmbH.
| ||||||
|---|---|---|---|---|---|---|
| Compound | R1 | R3 | R5 | X | IC50 (nM)a | Reference |
| 20 | CH2CH3 |
|
CF3 | C | < 1b | [146] |
| 21 | CH(CH3)2 |
|
CHF2 | C | < 1b | [146] |
| 22 |
|
|
CHF2 | C | < 1b | [146] |
| 23 |
|
|
CF3 | C | < 1c | [147] |
| 24 |
|
CH3 | CF3 | C | < 1c | [147] |
| 25 |
|
CH3 | CF3 | N | 3.7c | [147] |
| 26 |
|
|
CF3 | N | 2.8c | [147] |
| 27 |
|
|
CF3 | N | 2.3c | [147] |
| 28 |
|
|
CHF2 | C | < 1c | [147] |
| 29 | CH(CH3)2 |
|
CHF2 | C | 3 | [148] |
The results are means of two independent experiments, each performed in duplicate (HNE enzyme assay).
IC50 values are related to the racemate.
IC50 values are related to eutomer [(R)-enantiomer].